Canagliflozin: New Medication for Type 2 Diabetes Mellitus Canagliflozin (trade name Invokana) has been approved for monotherapy or combination therapy with other oral hypoglycemics and insulin for the treatment of type - Canagliflozin - Document - PDFSEARCH.IO

First Page	Meta Content
	Canagliflozin: New Medication for Type 2 Diabetes Mellitus Canagliflozin (trade name Invokana) has been approved for monotherapy or combination therapy with other oral hypoglycemics and insulin for the treatment of type Add to Reading List Document Date: 2014-07-15 15:35:38 Open Document File Size: 324,29 KB Share Result on Facebook Company McCulloch D. Management / / Continent Europe / / Country United States / Canada / / Currency USD / / IndustryTerm online database / / MedicalCondition Lu L. Diabetes / hyperkalemia / vulvovaginal candidiasis / penile candidiasis / diabetes mellitus / hyperphosphatemia / hyperkalemia e.g. / urinary tract infections / constipation / minimal hypoglycemia / nausea / diabetes / hypotension / / Person Murdoch L. Invokana / Karen Jensen / Dorothy Sanderson / / Position Pharmacist / / Product phenytoin / rifampin / Digoxin / / Technology UDP / / URL http / SocialTag Health Anti-diabetic medication Diabetes management Diuretic Glycated hemoglobin Sulfonylurea Metformin Diabetes mellitus type 2 Diabetes mellitus Medicine

Canagliflozin: New Medication for Type 2 Diabetes Mellitus Canagliflozin (trade name Invokana) has been approved for monotherapy or combination therapy with other oral hypoglycemics and insulin for the treatment of type Add to Reading List